Export financials
Mannatech, Incorporated (MTEX)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.

Mannatech, Incorporated Income Statement 2025-2006 | MTEX
Brief overview of financial performance at Mannatech, Incorporated
The comparison covers a five-year financial horizon. Revenue at Mannatech, Incorporated moved from 151 million dollars in 2020 to 108 million dollars in 2025. The cumulative result was −28.6%, corresponding to roughly −6.5% per year. The negative rate indicates weakening core operations.
Gross profit changed from $116 million to $81 million (−30.1%). Direct costs broadly followed the top-line trend. At the margin level, the figure shifted from 76.5% to 74.9%. There was no meaningful shift in gross profitability.
EBITDA changed from 6.5 million dollars to 666 thousand dollars (−89.7%). The operating result developed less favorably than sales. EBITDA margin moved from 4.3% to 0.6%. The business retained less EBITDA from each unit of revenue.
The net financial result changed from 6.3 million dollars to −15.2 million dollars. A positive result was not sustained and the period ended with a loss.
Over the period, capitalization shifted from 38.9 million dollars to 9.4 million dollars (−75.7%). The financial trend was stronger than the market valuation.
Overall conclusion
Signs of deterioration dominate the five-year picture. The main areas of concern are a weaker market valuation, a lower gross margin and pressure on operating profitability. Future reports should be judged by revenue momentum, margins, and the conversion of sales into net income.
Annual Income Statement Mannatech, Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
9.43 M | 9.35 M | 15.3 M | 33.7 M | 65.4 M | 38.9 M | 35.7 M | 48.4 M | 38.9 M | 51.1 M | 47.2 M | 49.8 M | 40.1 M | 15.9 M | 11.9 M | 62.5 M | 78.6 M | 1.6 B | 3.69 B | - |
Shares |
1.9 M | 1.88 M | 1.87 M | 1.91 M | 1.94 M | 2.1 M | 2.39 M | 2.54 M | 2.71 M | 2.69 M | 2.68 M | 2.66 M | 2.65 M | 2.65 M | 2.65 M | 2.65 M | 2.65 M | 26.5 M | 26.4 M | - |
Historical Prices |
4.96 | 4.96 | 8.22 | 17.6 | 33.7 | 17.1 | 13.9 | 16 | 11.5 | 15.3 | 13.5 | 14.3 | 11.7 | 4.74 | 3.45 | 23.6 | 29.7 | 60.4 | 140 | 139 |
Net Income |
-15.2 M | 2.5 M | -2.2 M | -4.49 M | 9.84 M | 6.26 M | 3.29 M | -3.89 M | -1.79 M | -586 K | 5.84 M | 6.5 M | 3.17 M | -1.39 M | -20.7 M | -10.6 M | -17.4 M | -12.6 M | 6.59 M | - |
Revenue |
108 M | 118 M | 132 M | 137 M | 160 M | 151 M | 158 M | 174 M | 177 M | 180 M | 180 M | 190 M | 177 M | 173 M | 201 M | - | - | - | - | - |
Cost of Revenue |
27.1 M | 26.4 M | 29.1 M | 33.1 M | 34.1 M | 35.5 M | 31.6 M | 34.5 M | 35.7 M | 36.6 M | 34.1 M | 38.4 M | 36.1 M | 34.6 M | 38.5 M | 32.8 M | 46.8 M | 48.6 M | 59.8 M | - |
Gross Profit |
81 M | 91.5 M | 103 M | 104 M | 126 M | 116 M | 126 M | 139 M | 141 M | 144 M | 146 M | 152 M | 141 M | 139 M | 82.8 M | 98 M | 96.5 M | 135 M | 164 M | - |
Operating Income |
-426 K | 1.43 M | -964 K | -405 K | 9.05 M | 4.49 M | 6.43 M | -90 K | 2.52 M | 661 K | 12.1 M | 12.7 M | 4.76 M | -980 K | -16.9 M | -11.5 M | -25.6 M | -14.5 M | 7.61 M | - |
Interest Expense |
-2.06 M | 2.59 M | -170 K | -162 K | -223 K | 1.15 M | -681 K | 291 K | -333 K | -1.79 M | -4.16 M | -3.04 M | -1.97 M | 630 K | -1.11 M | 268 K | 1.05 M | -5.3 M | 180 K | - |
EBITDA |
666 K | 2.96 M | 664 K | 1.22 M | 10.8 M | 6.48 M | 8.52 M | 1.97 M | 4.38 M | 2.6 M | 13.9 M | 14.4 M | 5.88 M | 3.78 M | -6.19 M | 36 K | -13.3 M | -2.19 M | 17.8 M | - |
Operating Expenses |
81.4 M | 90 M | 104 M | 105 M | 117 M | 111 M | 120 M | 139 M | 139 M | 143 M | 134 M | 139 M | 138 M | 140 M | 99.7 M | 109 M | 122 M | 149 M | 156 M | - |
General and Administrative Expenses |
39.7 M | 41.7 M | 50.2 M | 47.4 M | 29.4 M | - | - | 73.5 M | 74.6 M | 74.2 M | 73 M | 75.2 M | 75.6 M | 73.8 M | - | 62.7 M | 70 M | 81.1 M | 84.3 M | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement Mannatech, Incorporated
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q4 | 2009-Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
1.9 M | 1.93 M | - | 1.9 M | 1.9 M | 1.88 M | 1.88 M | 1.88 M | 1.88 M | 1.86 M | 1.86 M | 1.87 M | 1.87 M | 1.86 M | - | 1.94 M | 1.95 M | 1.94 M | 1.9 M | 2.06 M | 2.07 M | 2.07 M | 2.1 M | 2.37 M | 2.39 M | 2.38 M | 2.39 M | 2.39 M | 2.4 M | 2.38 M | 2.4 M | 2.67 M | 2.72 M | 2.7 M | 2.71 M | 2.71 M | 2.7 M | 2.69 M | 2.71 M | 2.71 M | 2.7 M | 2.68 M | 2.68 M | 2.68 M | 2.68 M | 2.68 M | 2.67 M | 2.66 M | 2.65 M | 2.65 M | 2.65 M | 2.65 M | 2.65 M | 2.65 M | 2.65 M | 2.65 M | 2.65 M | 2.65 M | 2.65 K | 2.65 M | 2.65 K | - | 26.5 M | 26.5 M | 26.5 M | - | 26.5 M |
Net Income |
-1.53 M | 950 K | - | 1.92 M | -1.53 M | - | -328 K | -624 K | 1.18 M | - | 18 K | -1.1 M | 604 K | - | - | 694 K | 134 K | - | 2.93 M | 2.13 M | 2.19 M | - | 1.62 M | 1.13 M | 2.79 M | - | -1.49 M | 1.99 M | 688 K | - | -1.66 M | -384 K | -264 K | - | 1.38 M | 1.8 M | -1.25 M | - | 1.28 M | -1.33 M | 591 K | - | 68 K | 3.14 M | 1.1 M | - | 5.11 M | -692 K | 228 K | - | -801 K | 784 K | 644 K | - | 2.21 M | -2.46 M | -1.4 M | - | -3.66 M | -5.25 M | -4.78 M | - | -1.28 M | -3.82 M | -2.78 M | - | -9.21 M |
Revenue |
25.7 M | 24.9 M | - | 29.2 M | 26.6 M | - | 31.7 M | 27.7 M | 29.4 M | - | 32.6 M | 32.6 M | 34.1 M | - | - | 35 M | 32.4 M | - | 39.4 M | 42.5 M | 38.3 M | - | 38 M | 37.6 M | 36.6 M | - | 39.7 M | 40.7 M | 38 M | - | 43 M | 45.1 M | 41.4 M | - | - | - | - | - | - | - | 40.7 M | - | 43.9 M | 46.7 M | 44.4 M | - | 55.6 M | 46.3 M | 43 M | - | 44.4 M | 44.8 M | 41.7 M | - | 43 M | 43.6 M | 44.5 M | - | 50.5 M | 51.4 M | - | - | - | - | - | - | - |
Cost of Revenue |
6.78 M | 6.06 M | - | 6.89 M | 6.83 M | - | 8.1 M | 6.36 M | 6.3 M | - | 6.62 M | 7 M | 7.41 M | - | - | 7.92 M | 7.09 M | - | 7.9 M | 10.1 M | 7.22 M | - | 9.33 M | 8.71 M | 7.01 M | - | 7.71 M | 8.12 M | 7.43 M | - | 9.04 M | 8.14 M | 8.25 M | - | 8.23 M | 8.79 M | 8.76 M | - | 9.74 M | 10.1 M | 8.39 M | - | 8.25 M | 8.27 M | 8.55 M | - | 10.3 M | 9.74 M | 9.4 M | - | 9.22 M | 8.69 M | 7.7 M | - | 8.7 M | 8.85 M | 8.28 M | - | 7.41 M | 7.54 M | 7.21 M | - | 7.92 M | 8.09 M | 8.62 M | - | 11.9 M |
Gross Profit |
18.9 M | 18.9 M | - | 22.3 M | 19.7 M | - | 23.6 M | 21.4 M | 23.1 M | - | 25.9 M | 25.6 M | 26.7 M | - | - | 27.1 M | 25.3 M | - | 31.5 M | 32.4 M | 31.1 M | - | 28.6 M | 28.9 M | 29.6 M | - | 31.9 M | 32.6 M | 30.5 M | - | 34 M | 37 M | 33.1 M | - | 33.8 M | 38.9 M | 31.9 M | - | 38.4 M | 38.7 M | 32.3 M | - | 35.6 M | 38.5 M | 35.8 M | - | 45.3 M | 36.6 M | 33.6 M | - | 35.2 M | 36.1 M | 34 M | - | 34.4 M | 34.8 M | 36.2 M | - | 21.1 M | 20.9 M | 22 M | - | 23.8 M | 25 M | 25 M | - | 24.1 M |
Operating Income |
-1.44 M | -180 K | - | 2.01 M | -833 K | - | 887 K | -1.14 M | 820 K | - | 172 K | -954 K | 713 K | - | - | 853 K | 35 K | - | 3.29 M | 2.02 M | 2.79 M | - | 1.38 M | 1.11 M | 2.01 M | - | 565 K | 2.02 M | 1.12 M | - | 1.67 M | -349 K | -888 K | - | 684 K | 2.82 M | -2.03 M | - | 507 K | -112 K | 536 K | - | 2.23 M | 4.61 M | 2.51 M | - | 8.2 M | 600 K | 1.38 M | - | 429 K | 1.55 M | 655 K | - | 1.09 M | -1.41 M | -2.06 M | - | -1.57 M | -4.32 M | -4.91 M | - | -3.66 M | -2.13 M | -2.89 M | - | -8.57 M |
Interest Expense |
-2.74 M | 1.4 M | - | 611 K | -418 K | - | -1.5 M | 1.12 M | 871 K | - | 320 K | 150 K | 333 K | - | - | -84 K | 85 K | - | -19 K | 152 K | -282 K | - | 248 K | 166 K | -208 K | - | -430 K | 980 K | 4 K | - | -83 K | 476 K | 288 K | - | 177 K | -9 K | 41 K | - | 232 K | -1.04 M | 334 K | - | -2.42 M | -452 K | -932 K | - | -1.17 M | 192 K | -336 K | - | -275 K | -1.42 M | 417 K | - | 455 K | -805 K | 892 K | - | -1.56 M | 196 K | 267 K | - | 400 K | -715 K | 140 K | - | 859 K |
EBITDA |
-1.44 M | 81 K | - | - | -540 K | - | 1.29 M | -743 K | 1.24 M | - | - | -567 K | 1.1 M | - | - | 1.15 M | 367 K | - | 3.69 M | 2.46 M | 3.3 M | - | 1.85 M | 1.65 M | 2.53 M | - | 1.08 M | 2.54 M | 1.65 M | - | 2.14 M | 186 K | -377 K | - | 1.11 M | 3.27 M | -1.53 M | - | 1.01 M | 365 K | 979 K | - | 2.67 M | 5.1 M | 2.91 M | - | 8.64 M | 1.02 M | 1.76 M | - | 903 K | 2.14 M | 1.29 M | - | 1.79 M | -485 K | 402 K | - | 1.07 M | -1.63 M | -2.1 M | - | -889 K | 873 K | 25 K | - | -5.49 M |
Operating Expenses |
20.3 M | 19 M | - | 20.3 M | 20.6 M | - | 22.7 M | 22.5 M | 22.3 M | - | 25.8 M | 26.5 M | 26 M | - | - | 26.2 M | 25.3 M | - | 28.3 M | 30.4 M | 28.3 M | - | 27.3 M | 27.8 M | 27.6 M | - | 31.4 M | 30.6 M | 29.4 M | - | 32.3 M | 37.3 M | 34 M | - | 33.1 M | 36.1 M | 33.9 M | - | 37.9 M | 38.8 M | 31.8 M | - | 33.4 M | 33.8 M | 33.3 M | - | 37.1 M | 36 M | 32.2 M | - | 34.8 M | 34.6 M | 33.3 M | - | 33.3 M | 36.2 M | 38.3 M | - | 22.6 M | 25.2 M | 26.9 M | - | 27.5 M | 27.1 M | 27.9 M | - | 32.7 M |
General and Administrative Expenses |
10.8 M | 9.28 M | - | 9.07 M | 10 M | - | 9.84 M | 10.9 M | 10.6 M | - | 12.6 M | 13.1 M | 12 M | - | - | 6.91 M | 6.91 M | - | 7.16 M | 7.57 M | 7.11 M | - | 6.64 M | 7.16 M | 6.86 M | - | 8.95 M | 8.38 M | 7.58 M | - | 8.11 M | 9.62 M | 7.98 M | - | 8.17 M | 9.98 M | 8.65 M | - | 9.88 M | 9.73 M | 8.14 M | - | 9 M | 8.6 M | 8.81 M | - | 9.57 M | 8.95 M | 7.88 M | - | 8.5 M | 8.54 M | 8.63 M | - | 8.64 M | 9.94 M | 9.66 M | - | 12.4 M | 14.8 M | 16 M | - | 15.8 M | 15.3 M | 16.5 M | - | 17.7 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company Mannatech, Incorporated (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Household products industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
The Clorox Company
CLX
|
$ 106.6 | 1.01 % | $ 12.9 B | ||
|
The Estée Lauder Companies
EL
|
$ 113.35 | 0.17 % | $ 41.1 B | ||
|
Unilever PLC
UL
|
$ 66.48 | -0.2 % | $ 145 B | ||
|
Colgate-Palmolive Company
CL
|
$ 98.06 | 0.12 % | $ 79.3 B | ||
|
The Procter & Gamble Company
PG
|
$ 168.81 | 0.29 % | $ 394 B | ||
|
United-Guardian
UG
|
$ 9.01 | 1.81 % | $ 41.4 M | ||
|
USANA Health Sciences
USNA
|
$ 13.1 | -5.42 % | $ 243 M | ||
|
Revlon
REV
|
- | -4.41 % | $ 212 M | ||
|
Church & Dwight Co.
CHD
|
$ 111.77 | 0.41 % | $ 27.1 B | ||
|
Kimberly-Clark Corporation
KMB
|
$ 110.78 | -1.03 % | $ 36.8 B | ||
|
Hims & Hers Health
HIMS
|
$ 19.1 | -16.76 % | $ 4.3 B | ||
|
Coty
COTY
|
$ 4.34 | 2.73 % | $ 3.81 B | ||
|
e.l.f. Beauty
ELF
|
$ 118.5 | -0.71 % | $ 6.9 B | ||
|
Dogness (International) Corporation
DOGZ
|
$ 0.44 | -1.36 % | $ 7.84 M | ||
|
Helen of Troy Limited
HELE
|
$ 38.19 | 2.28 % | $ 878 M | ||
|
Newell Brands
NWL
|
$ 5.94 | 0.76 % | $ 2.48 B | ||
|
Acme United Corporation
ACU
|
$ 70.35 | 1.6 % | $ 266 M | ||
|
Edgewell Personal Care Company
EPC
|
$ 29.61 | 0.25 % | $ 1.41 B | ||
|
LifeVantage Corporation
LFVN
|
$ 4.64 | -12.29 % | $ 58.2 M | ||
|
Inter Parfums
IPAR
|
$ 135.62 | -0.4 % | $ 4.35 B | ||
|
Nature's Sunshine Products
NATR
|
$ 10.89 | -1.23 % | $ 196 M | ||
|
Nu Skin Enterprises
NUS
|
$ 4.04 | -5.61 % | $ 199 M | ||
|
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - | |
|
Spectrum Brands Holdings
SPB
|
$ 88.66 | -0.75 % | $ 2.28 B |